(Press-News.org) Temptations to exceed the speed limit are always plentiful, but only reckless drivers give in to such impulses. Likewise, numerous growth factors always abound in our bodies, but only cancerous cells are quickly "tempted" by these chemicals to divide again and again. Healthy cells, in contrast, divide only after being exposed to growth factors for eight continuous hours. What happens during these eight hours in a healthy cell that resists the call to divide? And even more important, what fails to work properly in the cancerous cell during these same hours? Why do cancerous cells give in so easily to the influence of growth factors, dividing so readily?
Answers to these questions have emerged from a study by a multidisciplinary team of Weizmann Institute researchers published recently in Molecular Cell. The scientists found that when a cell first receives a signal from a growth factor, ten groups of genes, about 8,000 in total, become activated. Of these, one group, consisting of about ten genes governed by the tumor suppressor p53, is the most crucial: These genes prevent the cell from dividing. Only if the growth factor continues to affect the cell for eight hours does p53 release its grip on the cell's DNA, allowing it to divide. Like a careful driver who puts the brakes on before proceeding, the activation of p53 at the time the cell receives a growth factor signal serves as a "brake," preventing instant division. In this manner, the healthy cell ensures that it will not divide as a result of accidental, mistaken or otherwise superfluous growth signals, but only if the signal is continuous and necessary. In cancerous cells, this mechanism malfunctions because in most of them, p53 is defective or missing altogether, so that even a fleeting growth signal can cause them to divide, leading to cancerous growth.
This interdisciplinary study has resulted from a collaboration between three research teams at the Weizmann Institute, headed by Prof. Yosef Yarden of the Biological Regulation Department, Prof. Eytan Domany of the Physics of Complex Systems Department and Prof. Moshe Oren of the Molecular Cell Biology Department. The study was coordinated by former graduate student Dr. Yaara Zwang; taking part were Aldema Sas-Chen, Yotam Drier, Dr. Tal Shay, Roi Avraham, Dr. Mattia Lauriola, Efrat Shema and Efrat Lidor-Nili. Also taking part were clinical researchers: Dr. Jasmine Jacob-Hirsch, Dr. Ninette Amariglio and Prof. Gideon Rechavi of the Chaim Sheba Medical Center and Drs. Yiilng Lu and Gordon B. Mills of the M.D. Anderson Cancer Center at the University of Texas.
This research sheds new light on the differences between healthy and cancerous cells. It might help develop new effective approaches to chemotherapy. Cancerous tumors sometimes develop resistance to the therapy, among other reasons because it stresses the body. The stress, in turn, leads to the production of growth factors that cause cells to divide, so that the treatment ultimately defeats itself. A better understanding of how growth factors work can help identify intervals for chemotherapy that will prevent the increased division of cancerous cells.
INFORMATION:
Prof. Yosef Yarden's research is supported by the M.D. Moross Institute for Cancer Research; the Aharon Katzir-Katchalsky Center; the Kekst Family Institute for Medical Genetics; the Kirk Center for Childhood Cancer and Immunological Disorders; the Women's Health Research Center funded by the Bennett-Pritzker Endowment Fund, the Marvelle Koffler Program for Breast Cancer Research, the Harry and Jeanette Weinberg Women's Health Research Endowment, and the Oprah Winfrey Biomedical Research Fund; the Jean - Jacques Brunschwig Fund for the Molecular Genetics of Cancer; the Laub Fund for Oncogene Research; the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; the Steven and Beverly Rubenstein Charitable Foundation , Inc.; Julie Charbonneau, Canada; and the estate of Norman Davis. Prof. Yarden is the incumbent of the Harold and Zelda Goldenberg Professorial Chair in Molecular Cell Biology.
Prof. Moshe Oren's research is supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; the Robert Bosch Foundation; and the estate of Harold Z. Novak. Prof. Oren is the incumbent of the Andre Lwoff Professorial Chair in Molecular Biology.
Prof. Eytan Domany's research is supported by the Kahn Family Research Center for Systems Biology of the Human Cell; the Mario Negri Institute for Pharmacological Research - Weizmann Institute of Science Exchange Program; the Leir Charitable Foundation; and Mordechai Segal, Israel. Prof. Domany is the incumbent of the Henry J. Leir Professorial Chair.
The Weizmann Institute of Science in Rehovot, Israel, is one of the world's top-ranking multidisciplinary research institutions. Noted for its wide-ranging exploration of the natural and exact sciences, the Institute is home to 2,700 scientists, students, technicians and supporting staff. Institute research efforts include the search for new ways of fighting disease and hunger, examining leading questions in mathematics and computer science, probing the physics of matter and the universe, creating novel materials and developing new strategies for protecting the environment.
Weizmann Institute news releases are posted on the World Wide Web at http://wis-wander.weizmann.ac.il, and are also available at http://www.eurekalert.org.
END
The lab, though it may seem quiet and insulated, can be as full of background noise as a crowded train station when we're trying to catch the announcements. Our brains can filter out the noise and focus on the message up to a certain point, but turning up the volume on the loudspeakers – improving the signal-to-noise ratio – helps as well.
Separating out the signal from the noise – increasing one while reducing the other – is so basic that much of scientific research could not take place without it. One common method, developed by the physicist Robert Dicke at Princeton ...
The molecular machines that defend our body against infection don't huff and puff, but some of them The molecular machines that defend our body against infection don't huff and puff, but some of them apparently operate on the same principle as a steam engine. Weizmann Institute scientists have discovered a mechanism that controls inflammation similarly to a steam-engine valve: Just when the inflammatory mechanism that protects cells against viruses reaches its peak of activity, the molecular "steam-release valve" interferes, restoring this mechanism to its resting state, ...
Establishing an economically and environmentally beneficial, 'bio-derived' Australian and New Zealand aviation fuels industry is a viable proposition, according to a report compiled by CSIRO in collaboration with the region's major aviation industry players.The report, Flight Path to Sustainable Aviation, predicts that over the next 20 years a new, sustainable, Australia-New Zealand aviation fuels industry could cut greenhouse gas emissions by 17 per cent, generate more than 12,000 jobs and reduce Australia's reliance on aviation fuel imports by $2 billion per annum.
"This ...
A team of scientists from the University of Sheffield and Bangor University have used a computer climate model to study how freshwater entering the oceans at the end of the penultimate Ice Age 140,000 years ago affected the parts of the ocean currents that control climate.
A paper based on the research, co-authored by Professor Grant Bigg, Head of the University of Sheffield's Department of Geography, his PhD student Clare Green, and Dr Mattias Green, a Senior Research fellow at Bangor University's School of Ocean Sciences, is currently featured as an Editor's Highlight ...
Vitamin D is important for optimal reproductive function in both animals and humans. It has long been known that serum vitamin D level is important for reproductive function in various animals, but now researchers from the University of Copenhagen and Copenhagen University Hospital have shown that this relationship can also be demonstrated in humans.
A new study conducted in 300 normal men showed a positive correlation between the percentage of motile sperm and serum vitamin D levels. The study was recently published in the scientific journal Human Reproduction, and showed ...
Groundbreaking research has shown a quantum atom has been tracked inside a living human cell and may lead to improvements in the testing and development of new drugs.
Professor Lloyd Hollenberg from the University of Melbourne's School of Physics who led the research said it is the first time a single atom encased in nanodiamond has been used as a sensor to explore the nanoscale environment inside a living human cell.
"It is exciting to see how the atom experiences the biological environment at the nanoscale," he said.
"This research paves the way towards a new class ...
Scientists have discovered an important enzyme molecule that may prevent fatal cardiac disorders associated with cardiac hypertrophy – the leading cause of sudden cardiac death in young athletes.
Cardiac hypertrophy is a disease of the heart muscle where a portion of the tissue is thickened without any obvious cause. It is commonly linked to high blood pressure (hypertension) and excessive exercises and results in a shrinking of the heart chamber and a reduction of its blood-pumping volume.
The condition is also associated with fatal cardiac disorders related to irregular ...
Research led by the University of Warwick's Centre for Competitive Advantage in the Global Economy has found that not only did the events of 9/11 produce an immediate shift in favour of the Republican party among new young US voters but that shift persisted into later years. The research shows that party strategists should focus on winning over voters when they are young.
The researchers Professor Sharun Mukand, from the University of Warwick, and Professor Ethan Kaplan, from Stockholm University and the University of Maryland, looked at whether the mere act of registering ...
For many patients with the hepatitis C virus (HCV), direct antiviral agents (DAA) offer a potential cure for the disease. The Food and Drug Administration (FDA) has recently approved two new DAAs, telaprevir and boceprevir, and with that clinicians must now decide who should be the first to receive this treatment. Discussion of this timely topic is now available in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
The World Health Organization (WHO) estimates up to 170,000 million ...
Scientists are reporting development and successful testing of a promising new way of using a troublesome byproduct of the global steel industry as raw materials for bricks that can be used in construction projects. Their study appears in ACS' Industrial & Engineering Chemistry Research.
In the report, Ana Andrés and colleagues note that steel mills around the world produce vast quantities of waste dust each year — 8 million – 12 million tons in the United States, for instance, and 700,000 tons in the European Union countries. The dust often is converted into a rock-like ...
